Bertran Auvert: Unterschied zwischen den Versionen
KKeine Bearbeitungszusammenfassung |
K REFjournal uses <init> key |
||
| Zeile 20: | Zeile 20: | ||
'''Bertran Auvert''' ist ein [[Befangenheit|voreingenommener]] Beschneidungsforscher französischer Herkunft, der sich seit mindestens 2003 für die Beschneidung einsetzt.<ref>{{REFjournal | '''Bertran Auvert''' ist ein [[Befangenheit|voreingenommener]] Beschneidungsforscher französischer Herkunft, der sich seit mindestens 2003 für die Beschneidung einsetzt.<ref>{{REFjournal | ||
|last=Rain-Taljaard | |last=Rain-Taljaard | ||
| | |init=RC | ||
|last2=Lagarde | |last2=Lagarde | ||
| | |init2=E | ||
|last3=Taljaard | |last3=Taljaard | ||
| | |init3=DJ | ||
|last4=Campbell | |last4=Campbell | ||
| | |init4=C | ||
|last5=MacPhail | |last5=MacPhail | ||
| | |init5=C | ||
|last6=Williams | |last6=Williams | ||
| | |init6=B | ||
|last7=Auvert | |last7=Auvert | ||
| | |init7=B | ||
|author7-link=Bertran Auvert | |author7-link=Bertran Auvert | ||
|title=Potential for an intervention based on male circumcision in a South African town with high levels of HIV infection | |title=Potential for an intervention based on male circumcision in a South African town with high levels of HIV infection | ||
| Zeile 43: | Zeile 43: | ||
|last=Auvert | |last=Auvert | ||
|first=Bertran | |first=Bertran | ||
|init=B | |||
|author-link=Bertran Auvert | |author-link=Bertran Auvert | ||
|last2=Taljaard | |||
|first2=Dirk | |first2=Dirk | ||
| | |init2=D | ||
|last3=Lagarde | |||
|first3=Emmanuel | |first3=Emmanuel | ||
| | |init3=E | ||
|last4=Sobngwi-Tambekou | |||
|first4=Joëlle | |first4=Joëlle | ||
| | |init4=J | ||
|last5=Sitta | |||
|first5=Rémi | |first5=Rémi | ||
| | |init5=R | ||
|last6=Puren | |||
|first6=Adrian | |first6=Adrian | ||
| | |init6=A | ||
|date=2005-10-25 | |date=2005-10-25 | ||
|title=Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial | |title=Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial | ||